Lexicon Pharmaceuticals
LXRX
#6570
Rank
S$0.92 B
Marketcap
S$2.19
Share price
-2.27%
Change (1 day)
213.66%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of September 2025 : S$0.15 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has S$0.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$0.19 B61.33%
2023-12-31$S$0.12 B-21.68%
2022-12-31$S$0.15 B2.24%
2021-12-31$S$0.15 B-25.76%
2020-12-31$S$0.20 B31.04%
2019-12-31$S$0.15 B-537.65%
2018-12-31$-S$36.08 Million-139.51%
2017-12-31$S$91.3 M-59.92%
2016-12-31$S$0.22 B-43.66%
2015-12-31$S$0.40 B7.74%
2014-12-31$S$0.37 B74.07%
2013-12-31$S$0.21 B-33.89%
2012-12-31$S$0.32 B-15.37%
2011-12-31$S$0.38 B21.11%
2010-12-31$S$0.31 B38.63%
2009-12-31$S$0.22 B-18.04%
2008-12-31$S$0.28 B-32.09%
2007-12-31$S$0.41 B214.53%
2006-12-31$S$0.13 B-8.23%
2005-12-31$S$0.14 B-27.98%
2004-12-31$S$0.19 B-29.76%
2003-12-31$S$0.28 B-4.21%
2002-12-31$S$0.29 B-27.07%
2001-12-31$S$0.40 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Thermo Fisher Scientific
TMO
S$68.31 B 44,454.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$3.47 B 2,166.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$39.88 B 25,912.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-S$93.16 Million-160.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$1.29 B 746.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$0.58 Billion-475.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$0.21 Billion-236.47%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$7.76 B 4,965.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$4.55 M-97.03%๐Ÿ‡บ๐Ÿ‡ธ USA